- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06188728
Husk Fiber Intervention on Metabolic Health of Centrally Obese School Teachers
January 3, 2024 updated by: Amjad Ali Bacha, University of Peshawar
Effectiveness of Lifestyle Modification in Combination With Psyllium Husk Fiber Intervention on the Metabolic Health of Centrally Obese School Teachers
A group of 120 school teachers (male=60, female=60) was divided into four subgroups for sixteen weeks of an interventional study.
One group was kept in control while the other three groups were assigned intervention.
One group was assigned intervention of lifestyle modification (LSM), the other group assigned the intervention of 5 gm psyllium husk fiber (PSH) two times a day, and the third group assigned the combined intervention of LSM & PSH.
Each group comprised of 30 subjects with equal gender bifurcation (15 male and 15 female).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
- Other: Control
- Behavioral: Effect of life style modification (Diet, Behavior and physical activity)
- Dietary supplement: effect of 10 gm psyllium husk fiber twice a day, 30 minutes before breakfast and dinner
- Combination product: Combined effect of 10 gm Psyllium husk fiber and lifestyle modification
Detailed Description
The school teachers who qualified for the initial screening and eligibility criteria were formally enrolled in the intervention.
An informed consent form was signed by each subject explaining the data privacy and the subject's obligation.
School teachers with lifestyle modification were advised to adhere to three major components, i.e., diet modification, physical activity, and behavioral therapy.
subjects in the psyllium husk fiber group were assigned the consumption of 5gm psyllium husk fiber (in swelled form) two times a day, i.e., 30 minutes before breakfast and 30 minutes before dinner.
subjects in the combined group of psyllium husk fiber and physical activity were assigned both the intervention of psyllium husk fiber @ 5gm two times a day, 30 minutes before breakfast and dinner in swelled gel form with the combination of lifestyle modification, while one group remained as control (without any intervention).
Study Type
Interventional
Enrollment (Actual)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Khyberpakhtunkhwa
-
Peshawar, Khyberpakhtunkhwa, Pakistan, 25000
- The University of Agriculture
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- School teachers aged 40-60 years (male and female)
- central obesity (where central obesity for Asians is defined as the waist circumference for men ≥ 90 cm and for women ≥ 80 cm
- with no history of any chronic disease like hypertension, Diabetes, Cardiovascular diseases, taking of any regular medication, food allergies, smoking
- physical disabilities impairing the food intake and mobility, qualified the inclusion criteria.
Exclusion Criteria:
- Pregnant or lactating female school teachers were also excluded during screening.
- Subjects with an allergy to psyllium husk fiber, history of drug abuse, or any psychological or emotional disorder that might prevent the completion of the study were also excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Control group
Group-I comprised of 30 subjects, 15 male and 15 female.
The group was assigned no intervention and kept as the control group.
|
No intervention
|
|
Experimental: LSM group
Group II comprised 30 subjects with the equal bifurcation of male and female.
Group II was assigned the intervention of lifestyle modification (the combination of diet, physical activity, and behavior therapy)
|
To assess the effect of life style modification (Diet, Behavior and physical activity) on centrally obese school teachers
|
|
Experimental: PSH group
Group III comprised of 30 subjects, 15 male and 15 female. Group III was assigned the 5gm psyllium husk fiber (in swelled form) two times a day, i.e., 30 minutes before breakfast and 30 minutes before dinner. All the subjects in the physical demonstration were briefed about the preparation and usage of psyllium husk fiber. |
comparing the effect of psyllium husk fiber and lifestyle modification alone with the combined effect of psyllium husk fiber on metabolic health of centrally obese school teachers
|
|
Experimental: LSM&PSH
Group IV comprised of 30 subjects, 15 male and 15 female.
Group IV was assigned both the intervention of psyllium husk fiber @ 5gm two times a day, 30 minutes before breakfast and dinner in swelled gel form with the combination of lifestyle modification
|
To evaluate the combined effect of 10 gm psyllium husk fiber in gel form, 30 minutes before breakfast and dinner along with dietary, behavioral and physical activity modification on centrally obese school teachers
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anthropometry
Time Frame: 16 weeks
|
weight (Kg),
|
16 weeks
|
|
Lipid Profile
Time Frame: 16 weeks
|
Triglyceride, LDL, HDL and cholesterol.
unit used was mg/dl.
|
16 weeks
|
|
Sleep quality analysis
Time Frame: 16 weeks
|
wil use Pittesburge Sleep Quality Index score (ranging from 0 to 6. where 0 reflect best sleep quality and 7 represent the worst sleep quality)
|
16 weeks
|
|
abdomen and epigastric health
Time Frame: 16 weeks
|
Likert scale (0-7).
0 represents good health and 7 represent worst epigastric and abdominal health
|
16 weeks
|
|
height (cm)
Time Frame: 16 weeks
|
Measure height in cm (centimeter)
|
16 weeks
|
|
Waist circumference
Time Frame: 16 weeks
|
Measure waist circumference in cm (centimeter)
|
16 weeks
|
|
BMI
Time Frame: 16 weeks
|
weight and height will be combine to calculate the BMI (kg/m^2)
|
16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insulin resistance
Time Frame: 16 weeks
|
will measure insulin resistance(Molar unit)
|
16 weeks
|
|
high sensitive C reactive protein
Time Frame: 16 weeks
|
assess the inflammation biomarkers(mg/l)
|
16 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Zia Din, PhD, Chairman department of human Nutrition
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 7, 2020
Primary Completion (Actual)
May 27, 2021
Study Completion (Actual)
July 30, 2021
Study Registration Dates
First Submitted
March 14, 2022
First Submitted That Met QC Criteria
January 1, 2024
First Posted (Actual)
January 3, 2024
Study Record Updates
Last Update Posted (Actual)
January 5, 2024
Last Update Submitted That Met QC Criteria
January 3, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UPeshawar
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
once the paper is approved and research data updated to HEC digital library
IPD Sharing Time Frame
once the research paper published
IPD Sharing Access Criteria
through google scholar
IPD Sharing Supporting Information Type
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Metabolic Disease
-
Yonsei UniversityUnknownCardiovascular Disease | Metabolic DiseaseKorea, Republic of
-
Clinical Nutrition Research Centre, SingaporeCompletedCardiovascular Disease | Metabolic Disease
-
San Diego State UniversityRecruitingBone Disease, MetabolicUnited States
-
Hospital Clinic of BarcelonaNovartisCompletedBone Disease, MetabolicSpain
-
Oneness Biotech Co., Ltd.Recruiting
-
Istituto Ortopedico RizzoliCompletedOsteopenia | Bone Disease, MetabolicItaly
-
The Hospital for Sick ChildrenRare Disease Foundation, Vancouver, CanadaCompleted
-
National Institutes of Health Clinical Center (CC)CompletedVascular Diseases | Cancer | Metabolic Bone Disease | Inflammatory DiseaseUnited States
-
Shenzhen Center for Chronic Disease ControlCompletedNutrition Disorders | Genetic Predisposition to Disease | Metabolic DiseaseChina
-
Stanley Dudrick's Memorial HospitalCompletedMetabolic Bone DiseasePoland
Clinical Trials on Control
-
Vanderbilt University Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)Enrolling by invitationCritical Illness | Respiratory Failure | Mechanical VentilationUnited States
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryRecruitingIschemic Stroke, AcuteCanada, Australia
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Takeshi MorimotoUniversity of the RyukyusCompletedCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted